About Microarray Biochips
Biochips are bio-microsystems. Bio-microsystems are small integrated devices used for biochemical reactions, biological monitoring, research, academic studies, drug discovery, and much more. A microarray biochip is a that biochip on which various microarrays are assembled on a substrate that permits successful performance of complex biochemical reactions at the same time. Microarray biochips are used in various applications such as drug discovery and development, diagnostics and treatments, research and consumables, forensic medicines, and others.
Technavio’s analysts forecast the global microarray biochips market to grow at a CAGR of 15.56% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global microarray biochips market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
• APAC
• Europe
• North America
• ROW
Technavio's report, Global Microarray Biochips Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott
• Agilent Technologies
• Illumina
• PerkinElmer
• Thermo Fisher Scientific
Other prominent vendors
• BioChain
• Bio-Rad Laboratories
• Cepheid
• Fluidigm
• Merck
• SuperBioChips Laboratories
• US Biomax
Market driver
• Increase in market presence with collaboration strategy
• For a full, detailed list, view our report
Market challenge
• Lack of technical knowledge
• For a full, detailed list, view our report
Market trend
• Emerging LOC technology
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market overview
PART 05: Market landscape
• Market overview
• Global biochips market
• Five forces analysis
PART 06: Market segmentation by product
• Global biochips market by product
• Global biochips market by microarrays
• Global biochips market by analysis software
• Global biochips market by biochip instruments
• Global biochips market by reagents
PART 07: Market segmentation by application
• Global biochips market by application
• Global biochips market in drug discovery and development
• Global biochips market in diagnostics and treatments
• Global biochips market in research and consumables
• Global biochips market in forensic medicines
• Global biochips market in other applications
PART 08: Geographical segmentation
• Global biochips market by region
• Biochips market in North America
• Biochips market in Europe
• Biochips market in APAC
• Biochips market in ROW
PART 09: Decision framework
PART 10: Drivers and challenges
• Market drivers
• Market challenges
PART 11: Market trends
• Emerging LOC technology
• Growth in bioinformatics software industry
• Emergence of cost-effective technologies
• Increasing use of chemical microarray technology
PART 12: Vendor landscape
• Competitive scenario
• Key vendors in global biochips market
• Other prominent vendors
PART 13: Key vendor analysis
Abbott
• Agilent Technologies
• Illumina
• PerkinElmer
• Thermo Fisher Scientific
PART 14: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Global biochips market 2016
Exhibit 02: Global biochips market 2016 and 2021 ($ millions)
Exhibit 03: Forecast: Global biochips market 2016-2021
Exhibit 04: Five forces analysis
Exhibit 05: Global biochips market by product 2016 (%)
Exhibit 06: Global biochips market by product 2021 (%)
Exhibit 07: Global biochips market by microarrays 2016 and 2021 ($ millions)
Exhibit 08: Forecast: Global biochips market by microarrays 2016-2021
Exhibit 09: Segmentation of microarrays based on types 2016 (%)
Exhibit 10: Global biochips market by analysis software 2016 and 2021 ($ millions)
Exhibit 11: Forecast: Global biochips market by analysis software 2016-2021
Exhibit 12: Global biochips market by biochip instruments 2016 and 2021 ($ millions)
Exhibit 13: Forecast: Global biochips market by biochip instruments 2016-2021
Exhibit 14: Global biochips market by reagents 2016 and 2021 ($ millions)
Exhibit 15: Forecast: Global biochips market by reagents 2016-2021
Exhibit 16: Global biochips market by application 2016 (%)
Exhibit 17: Global biochips market by application 2021 (%)
Exhibit 18: Global biochips market in drug discovery and development 2016 and 2021 ($ millions)
Exhibit 19: Forecast: Global biochips market in drug discovery and development 2016-2021
Exhibit 20: Global biochips market in diagnostics and treatments 2016 and 2021 ($ millions)
Exhibit 21: Forecast: Global biochips market in diagnostics and treatments 2016-2021
Exhibit 22: Global biochips market in research and consumables 2016 and 2021 ($ millions)
Exhibit 23: Forecast: Global biochips market in research and consumables 2016-2021
Exhibit 24: Global biochips market in forensic medicines 2016 and 2021 ($ millions)
Exhibit 25: Forecast: Global biochips market in forensic medicines 2016-2021
Exhibit 26: Global biochips market in other applications 2016 and 2021 ($ millions)
Exhibit 27: Forecast: Global biochips market in other applications 2016-2021
Exhibit 28: Global biochips by region 2016 (%)
Exhibit 29: Global biochips by region 2021 (%)
Exhibit 30: Biochips market in North America 2016 and 2021 ($ millions)
Exhibit 31: Forecast: Biochips market in North America 2016-2021
Exhibit 32: Biochips market in Europe 2016 and 2021 ($ millions)
Exhibit 33: Forecast: Biochips market in Europe 2016-2021
Exhibit 34: Biochips market in APAC 2016 and 2021 ($ millions)
Exhibit 35: Forecast: Biochips market in APAC 2016-2021
Exhibit 36: Biochips market in ROW 2016 and 2021 ($ millions)
Exhibit 37: Forecast: Biochips market in ROW 2016-2021
Exhibit 38: Key vendors in global biochips market 2016
Exhibit 39: Abbott: Business segmentation by revenue 2016
Exhibit 40: Abbott: Geographical segmentation by revenue 2016
Exhibit 41: Agilent Technologies: Business segmentation by revenue 2016
Exhibit 42: Agilent Technologies: Product segmentation by revenue 2016
Exhibit 43: Illumina: Business segmentation by revenue 2016
Exhibit 44: Illumina: Geographical segmentation by revenue 2016
Exhibit 45: PerkinElmer: Business segmentation by revenue 2016
Exhibit 46: PerkinElmer: Geographical segmentation by revenue 2016
Exhibit 47: Thermo Fisher Scientific: Business segmentation by revenue 2016
Exhibit 48: Thermo Fisher Scientific: Geographic segmentation by revenue 2016
